Search

everythinglearnresearchcommunity

for

Search:↓

Inflammation and fibrosis are important factors in hair loss, but more research with better control samples is needed.

Dermoscopy is useful for diagnosing different types of hair loss.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Accurate diagnosis of pseudolymphomatous folliculitis is crucial to avoid mistaking it for more serious conditions.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Some breast cancer chemotherapy can cause permanent hair loss.

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

Researchers found that dissecting folliculitis of the scalp is linked to obesity, severity increases with duration and number of nodules, and early treatment is important to prevent scarring.

A child had a rare case of scarring hair loss with skin disease, which is hard to treat and stressful.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

Long-standing benign tumors can become cancerous, especially in people with weakened immune systems.

ILC1-like cells can independently cause alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

The new hydrogel treatment promotes faster hair growth and better skin health for hair loss.

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

Accurate diagnosis is crucial for effective treatment of similar hair loss conditions.

Pruritus is common in LPP and FFA, worsened by heat and stress, and relieved by cold, affecting quality of life.

Frontal fibrosing alopecia can be misdiagnosed as androgenetic alopecia in African American women.

A simple scalp scraping can effectively distinguish fibrosing alopecia from androgenetic alopecia with seborrheic dermatitis.

The conclusion is that a brown halo around hair follicles, seen in rapid hair loss, might be linked to inflammation or chemical exposure.

A rare skin condition causing scarring was successfully treated with topical erythromycin and benzoyl peroxide.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Erlotinib may cause scarring hair loss.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.